Healthcare · NIFTY 500
Granules India Limited
₹840.50 +41.25 (+5.16%) Updated 12 Nov, 8:49 pm IST
Today
- Open
- ₹802.00
- Prev close
- ₹799.25
- Day high
- ₹847.00
- Day low
- ₹797.00
- Volume
- 58.77 L
- Value traded
- ₹483.64 Cr
- Upper circuit
- ₹959.10
- Lower circuit
- ₹639.40
- 52W high
- ₹923.65
- 52W low
- ₹529.85
- 1 month
- -1.89%
- 6 months
- +5.83%
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Quarterly results
Results for each quarter
Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Revenue · QoQ (vs last quarter)
Revenue · YoY (vs a year ago)
Net profit · QoQ (vs last quarter)
Net profit · YoY (vs a year ago)
EPS (₹) · YoY (vs a year ago)
| ₹ Cr | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,156 | 1,176 | 1,180 | 967 | 1,138 | 1,197 | 1,210 | 1,297 | 1,388 | 1,471 | 1,477 | 1,560 |
| Other income | 0.7 | 1.9 | 2.1 | 3.3 | 5.7 | 1.9 | 16.3 | -1.1 | -3.6 | 8.8 | 2.3 | 10.7 |
| Total income | 1,156 | 1,178 | 1,182 | 970 | 1,143 | 1,199 | 1,226 | 1,296 | 1,384 | 1,479 | 1,479 | 1,571 |
| Raw material | 553 | 547 | 483 | 362 | 445 | 435 | 429 | 498 | 529 | 644 | 496 | 613 |
| Purchases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Employee cost | 157 | 152 | 164 | 159 | 168 | 169 | 203 | 219 | 226 | 240 | 255 | 258 |
| Other expenses | 251 | 299 | 273 | 237 | 304 | 338 | 336 | 355 | 352 | 374 | 375 | 408 |
| Total expenses | 986 | 1,002 | 1,000 | 841 | 991 | 1,033 | 1,056 | 1,120 | 1,182 | 1,233 | 1,239 | 1,327 |
| Operating profit | 250 | 256 | 259 | 203 | 230 | 283 | 221 | 278 | 308 | 368 | 339 | 338 |
| OPM % | 21.7% | 21.7% | 22.0% | 21.0% | 20.2% | 23.6% | 18.2% | 21.5% | 22.2% | 25.0% | 22.9% | 21.6% |
| Finance cost | 28.6 | 28.8 | 27.0 | 25.7 | 26.6 | 24.0 | 23.8 | 29.2 | 28.7 | 32.7 | 21.1 | 21.0 |
| Depreciation | 52.4 | 53.2 | 52.9 | 52.5 | 56.6 | 63.5 | 68.8 | 72.0 | 73.5 | 81.7 | 79.6 | 83.9 |
| Exceptional items | — | — | — | — | — | 30.8 | -25.9 | — | — | 15.9 | — | — |
| Profit before tax | 170 | 176 | 181 | 128 | 153 | 198 | 145 | 176 | 202 | 262 | 240 | 243 |
| Tax | 44.4 | 46.0 | 46.8 | 31.1 | 35.2 | 45.5 | 31.9 | 45.3 | 52.0 | 60.8 | 60.4 | 61.6 |
| Net profit | 126 | 130 | 135 | 97.2 | 118 | 152 | 113 | 131 | 150 | 202 | 180 | 182 |
| Profit to shareholders | 126 | 139 | 135 | 97.2 | 118 | 152 | 110 | 131 | 150 | — | 180 | 182 |
| EPS (₹) | 5.18 | 5.35 | 5.55 | 4.01 | 4.85 | 6.27 | 4.64 | 5.38 | 6.19 | 8.23 | 7.12 | 7.03 |
Profit & loss
Results for each year
8 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
Revenue · YoY (vs a year ago)
Net profit · YoY (vs a year ago)
| ₹ Cr | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,279 | 2,599 | 3,238 | 3,765 | 4,512 | 4,506 | 4,482 | 5,366 |
| Other income | 26.7 | 36.6 | 26.9 | 17.6 | 13.8 | 4.4 | 12.9 | 20.3 |
| Total expenses | 2,029 | 2,237 | 2,560 | 3,225 | 3,839 | 3,964 | 3,865 | 4,591 |
| Employee cost | 210 | 259 | 408 | 401 | 472 | 598 | 660 | 888 |
| Operating profit | 384 | 553 | 855 | 722 | 914 | 856 | 976 | 1,175 |
| OPM % | 16.8% | 21.3% | 26.4% | 19.2% | 20.3% | 19.0% | 21.8% | 21.9% |
| Finance cost | 28.5 | 27.0 | 26.3 | 23.2 | 55.9 | 106 | 103 | 114 |
| Depreciation | 105 | 137 | 151 | 159 | 184 | 207 | 226 | 296 |
| Profit before tax | 277 | 426 | 704 | 558 | 687 | 547 | 660 | 785 |
| Tax | 89.1 | 116 | 155 | 145 | 171 | 142 | 159 | 190 |
| Tax rate % | 32.2% | 27.2% | 22.0% | 26.0% | 24.8% | 25.9% | 24.0% | 24.2% |
| Net profit | 236 | 335 | 549 | 413 | 517 | 405 | 502 | 595 |
| Profit to shareholders | 0.0 | 0.0 | — | 413 | 517 | 426 | 502 | — |
| Net margin % | 0.0% | 0.0% | 17.0% | 11.0% | 11.4% | 9.4% | 11.2% | 11.1% |
| EPS (₹) | 9.28 | 13.15 | 21.95 | 16.60 | 21.00 | 16.72 | 20.68 | 24.46 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Shareholders' equity · YoY (vs a year ago)
| ₹ Cr | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Sep 26 |
|---|---|---|---|---|---|
| Shareholders' equity | 2,835 | 3,226 | 3,716 | 5,085 | 6,567 |
| Long-term borrowings | 149 | 69.0 | 312 | 297 | 0.0 |
| Short-term borrowings | 910 | 1,154 | 974 | 1,041 | 619 |
| Total borrowings | 1,059 | 1,223 | 1,286 | 1,338 | 619 |
| Current liabilities | 1,814 | 2,082 | 2,003 | 2,092 | 1,748 |
| Fixed assets (PPE) | 1,631 | 1,856 | 2,217 | 3,051 | 3,403 |
| Inventories | 1,149 | 1,301 | 1,343 | 1,673 | 1,861 |
| Trade receivables | 949 | 986 | 942 | 909 | 946 |
| Cash & equivalents | 292 | 381 | 466 | 880 | 945 |
| Current assets | 2,574 | 2,905 | 3,115 | 3,768 | 4,552 |
| Total assets | 4,905 | 5,521 | 6,253 | 7,720 | 8,872 |
| Debt / equity | 0.37 | 0.38 | 0.35 | 0.26 | 0.09 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
Operations · YoY (vs a year ago)
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 332 | 739 | 439 | 867 | 793 |
| Cash from investing | -380 | -191 | -360 | -691 | -773 |
| Cash from financing | 190 | -440 | 7.7 | -92.5 | 379 |
| Spent on fixed assets | -398 | -411 | -381 | -572 | -558 |
| Free cash flow | -65.7 | 328 | 58.8 | 295 | 235 |
| Net cash flow | 142 | 107 | 86.9 | 82.8 | 399 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Latest (30 Sep 2026)
- Promoter & group
- 37.39%
- Public (FIIs, mutual funds, retail…)
- 62.61%
- Promoter change, last quarter
- 0.00 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 1.75 Per Share
- Dividend - Rs 1.50 Per Share
- Annual General Meeting/Dividend - Rs 1.50 Per Share
- Dividend - Rs 1.50 Per Share
- Annual General Meeting
- Buy Back
- Annual General Meeting/Dividend - Rs 0.75 Per Share
- Interim Dividend - Rs 0.25 Per Share
Board meetings
- the financial results for the period ended September 30, 2026
- GRANULES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Finan…
- GRANULES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 21-Jul-2026 to inter-alia consider and approve the Unaudited Finan…
- the financial results for the period ended Jun 30, 2026
- the Quarterly Audited Financial results of the Company for the period ended March 2026 and Dividend.
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- General Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
- Monitoring Agency Report
- Analysts/Institutional Investor Meet/Con. Call Updates
- Press Release
Latest news
GRANULES Outlook for the WeekEquitypandit · 8 Nov, 1:30 pmGranules India block deal: 5.3% equity worth Rs 1,160 crore changes hands; promoter likely sellerMoneycontrol.com · 11 Sep, 12:30 pmWhat Granules India Bulls Got RightSimply Wall St · 7 Nov, 11:56 pmGranules surges 18% in 1 month; why pharma stock hits 52-week high today?Business Standard · 24 Dec, 1:30 pmGranules India Share Price Fall Streak after 4.58% dropUnivest · 1 Oct, 12:30 pmGranules India reports 39% jump in Q2 profit; share price trade lowerMoneycontrol.com · 3 Nov, 1:30 pmGranules India (NSEI:GRANULES) Stock Forecast & Analyst PredictionsSimply Wall St · 3 Nov, 1:30 pmGranules India Ltd. Share Price Today - Granules India Ltd. Stock Price Live NSE/BSECNBC TV18 · 3 Jan, 8:53 pmAbout
About Granules India Limited
Granules India Limited is an Indian pharmaceutical manufacturing company headquartered in Hyderabad, Telangana, India. The company is involved in the manufacture and sale of finished dosage forms (FDs), pharmaceutical formulation intermediates (PFIs), active pharmaceutical ingredients (APIs).
From Wikipedia (CC BY-SA 4.0).
Company details
- Company name
- Granules India Limited
- NSE symbol
- GRANULES
- BSE scrip code
- 532482
- ISIN
- INE101D01020
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 20 Jun 2005
- Face value
- ₹1 per share
- Market lot
- 1 share
- Shares issued
- 27.28 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Pharmaceuticals: Other
- Managing director / CEO
- Krishna Prasad Chigurupati
- Chair
- Krishna Prasad Chigurupati
- Headquarters
- Hyderabad, Telangana, India
- Registered address
- 15th Floor, Granules Tower,Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana, India.
- Founded
- 1984
- Employees
- 6,523
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- granulesindia.com
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories ₹11,485.00 +1.04%
-
ALKEMAlkem Laboratories ₹5,302.00 -2.68%
-
SUNPHARMASun Pharmaceutical Industries ₹1,885.00 -0.91%
-
LAURUSLABSLaurus Labs ₹2,400.00 -1.19%
-
AUROPHARMAAurobindo Pharma ₹1,807.20 -1.11%
-
ACUTAASAcutaas Chemicals ₹3,996.10 +2.02%
-
APOLLOHOSPApollo Hospitals Enterprise ₹8,515.00 -1.03%
-
MAXHEALTHMax Healthcare Institute ₹946.30 +1.94%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.